NASDAQ:AMRN
Amarin Corporation PLC Stock News
$0.87
+0.0148 (+1.72%)
At Close: Apr 26, 2024
Amarin (AMRN) Stock Sinks As Market Gains: What You Should Know
09:45pm, Friday, 05'th Jun 2020
In the latest trading session, Amarin (AMRN) closed at $6.68, marking a -1.18% move from the previous day.
FDA Approves Abiomed’s First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump
12:00am, Friday, 05'th Jun 2020
Abiomed (NASDAQ: ABMD) announces the United States Food and Drug Administration (FDA) has approved the company's investigational device exemption appl
Too Much Uncertainty Keeps This 5-Star Analyst Watching Amarin Stock From the Sidelines
11:15pm, Thursday, 04'th Jun 2020
Rewind to the end of 2019, and in the dead of winter, the sun appeared to be shining on biotech Amarin (AMRN). Vascepa, the company’s high triglycerides treatment and only product, had just received
COVID-19: Pharma giants seek DCGI's approval to manufacture, sell Remdesivir drug
06:48am, Thursday, 04'th Jun 2020
Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached the country's top drug regulator--Drug Controller General of India (DCGI) to seek its approval to manufacture and se
COVID-19 Therapeutics: The Leading Contenders
04:03am, Thursday, 04'th Jun 2020
While there is a huge interest in Covid-19 vaccine candidates, therapeutics are also an immediate need and will still be greatly in demand even after vaccines a
CVS Health Corp To Distribute New Diabetic Nutrition Beverage From Glucose Health, Inc.
12:00am, Wednesday, 03'rd Jun 2020India's drug regulator grants Gilead Sciences marketing authorization for remdesivir
04:02pm, Tuesday, 02'nd Jun 2020
Read more about India's drug regulator grants Gilead Sciences marketing authorization for remdesivir on Devdiscourse
COVID-19: India’s drug regulator grants Gilead Sciences marketing authorisation for remdesivir
01:19pm, Tuesday, 02'nd Jun 2020
An earlier study results showed that when treating patients with severe disease - those who require non-invasive supplemental oxygen - 5 days of remdesivir led to similar improvements as a 10-day cour
Novacyt shares drop as France refuses to refund virus test
10:52am, Tuesday, 02'nd Jun 2020
Read more about Novacyt shares drop as France refuses to refund virus test on Devdiscourse
India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir
06:59am, Tuesday, 02'nd Jun 2020
Read more about India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir on Devdiscourse
Strides Pharma gets USFDA nod for generic ointment to treat skin conditions
06:43am, Tuesday, 02'nd Jun 2020
Read more about Strides Pharma gets USFDA nod for generic ointment to treat skin conditions on Devdiscourse
India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir
03:23am, Tuesday, 02'nd Jun 2020
India's drug regulator has granted US pharma giant Gilead Sciences marketing authorisation for its anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients.
Sensex, Nifty close nearly 2% higher, shrug Moody’s downgrade
03:11am, Tuesday, 02'nd Jun 2020
Sensex advanced 522 points or 1.6% to close at 33,825. Nifty climbed 153 points or 1.6% to end at 9,979.Bajaj Finance, Kotak Bank and IndusInd Bank, surging 6-8% were top Sensex gainers
India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir
01:54am, Tuesday, 02'nd Jun 2020
India's drug regulator has granted US pharma giant Gilead Sciences marketing authorisation for its anti-viral drug remdesivir for 'restricted emergency use' on hospitalised COVID-19 patients in view o
India's drug regulator grants Gilead Sciences marketing authorization for remdesivir
07:27pm, Monday, 01'st Jun 2020
Read more about India's drug regulator grants Gilead Sciences marketing authorization for remdesivir on Devdiscourse
